$0.6473
-0.0187-2.81%
Últ. Act.: Oct 21, 4:02 AM
$0.6474
-0.0186-2.79%
Co-Diagnostics (CODX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-3.00 | $-3.60 | $-3.90 | $-5.70 |
| Actual | $-1.46 | $-4.06 | $-16.65 | $-4.80 |
| Surprise | +51.3% | -12.8% | -326.9% | +15.8% |
| Revenue | ||||
| Estimate | $200000 | $200000 | $150000 | $300000 |
| Actual | $166131 | $145954 | $263922 | $145380 |
| Surprise | -16.9% | -27.0% | +75.9% | -51.5% |
| Metric | Q3 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-2.40 |
| Revenue | |
| Consensus | $200000 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-1.46 | $-3.00 | 51.3 % |
| Q1 | May 14, 2026 | $-4.06 | $-3.60 | -12.8 % |
| Q4 | Mar 31, 2026 | $-16.65 | $-3.90 | -326.9 % |
| Q3 | Nov 13, 2025 | $-4.80 | $-5.70 | 15.8 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $166.13K | $200.00K | -16.9 % |
| Q1 | May 14, 2026 | $145.95K | $200.00K | -27.0 % |
| Q4 | Mar 31, 2026 | $263.92K | $150.00K | 75.9 % |
| Q3 | Nov 13, 2025 | $145.38K | $300.00K | -51.5 % |